Naikang Zhou

609 total citations
40 papers, 401 citations indexed

About

Naikang Zhou is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Naikang Zhou has authored 40 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 14 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Naikang Zhou's work include Lung Cancer Diagnosis and Treatment (10 papers), Lung Cancer Treatments and Mutations (9 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Naikang Zhou is often cited by papers focused on Lung Cancer Diagnosis and Treatment (10 papers), Lung Cancer Treatments and Mutations (9 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Naikang Zhou collaborates with scholars based in China, Philippines and Czechia. Naikang Zhou's co-authors include Juntang Guo, Xiangyang Chu, Chaoyang Liang, Weian Song, Xiaodong Tian, Yang Liu, Xi Liu, Wei Wang, Chenghua Luo and Yang Liu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Naikang Zhou

37 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naikang Zhou China 10 250 141 85 84 49 40 401
Juntang Guo China 9 231 0.9× 107 0.8× 73 0.9× 140 1.7× 57 1.2× 21 397
Hans Hamberg Sweden 9 135 0.5× 96 0.7× 135 1.6× 73 0.9× 27 0.6× 12 310
Joel L. Mayerson United States 7 197 0.8× 130 0.9× 60 0.7× 135 1.6× 96 2.0× 15 402
François Casteillo France 11 197 0.8× 204 1.4× 71 0.8× 62 0.7× 55 1.1× 30 366
Simone Terra United States 11 279 1.1× 173 1.2× 43 0.5× 68 0.8× 92 1.9× 21 404
Jane Dancer United States 7 166 0.7× 134 1.0× 54 0.6× 57 0.7× 32 0.7× 7 300
P S Hasleton United Kingdom 9 280 1.1× 137 1.0× 44 0.5× 78 0.9× 31 0.6× 11 404
Ulisses Ribaldo Nicolau Brazil 9 111 0.4× 84 0.6× 40 0.5× 57 0.7× 50 1.0× 28 243
Inge Losen Germany 7 279 1.1× 94 0.7× 157 1.8× 155 1.8× 18 0.4× 9 488
Edina Tolnay Hungary 11 238 1.0× 114 0.8× 33 0.4× 106 1.3× 41 0.8× 16 388

Countries citing papers authored by Naikang Zhou

Since Specialization
Citations

This map shows the geographic impact of Naikang Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naikang Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naikang Zhou more than expected).

Fields of papers citing papers by Naikang Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naikang Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naikang Zhou. The network helps show where Naikang Zhou may publish in the future.

Co-authorship network of co-authors of Naikang Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Naikang Zhou. A scholar is included among the top collaborators of Naikang Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naikang Zhou. Naikang Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Zhang, Ze-Yan, et al.. (2020). NAA10 promotes proliferation of renal cell carcinoma by upregulating UPK1B.. PubMed. 24(22). 11553–11560. 12 indexed citations
4.
Hou, Huiqing, Kai Liu, Mengdi Jiang, et al.. (2019). The safety and serious adverse events of approved ALK inhibitors in malignancies: a meta-analysis. SHILAP Revista de lepidopterología. 4 indexed citations
5.
Zhou, Naikang, et al.. (2018). Tracking significant modules and key genes for esophageal squamous cell carcinoma based on differential modules. Journal of Cancer Research and Therapeutics. 14(12). 1135–1135. 2 indexed citations
6.
Zhang, Tinghua, et al.. (2018). Differential expressions of MDM2 and TAP73 in cancer and cancer-adjacent tissues in patients with non-small-cell lung carcinoma. Pulmonology. 24(3). 155–163. 5 indexed citations
7.
Zhou, Naikang, et al.. (2018). Utilizing multiple pathway cross-talk networks reveals hub pathways in primary mediastinal B-cell lymphoma. Journal of Cancer Research and Therapeutics. 14(10). 694–694. 2 indexed citations
8.
9.
Zhou, Naikang, et al.. (2016). MiRNA-155 and miRNA-132 as potential diagnostic biomarkers for pulmonary tuberculosis: A preliminary study. Microbial Pathogenesis. 100. 78–83. 24 indexed citations
10.
11.
Guo, Juntang, et al.. (2014). [Thin-walled cystic lung cancer: an analysis of 24 cases and review of literatures].. SHILAP Revista de lepidopterología. 17(7). 553–6. 5 indexed citations
12.
Guo, Juntang, Xiangyang Chu, Yang Liu, et al.. (2014). Choice of therapeutic strategies in intrathoracic anastomotic leak following esophagectomy. World Journal of Surgical Oncology. 12(1). 402–402. 28 indexed citations
13.
Zhou, Naikang, et al.. (2013). Pleuropneumonectomy for diffuse pleural metastasis in primary lung cancer. Journal of Cancer Research and Therapeutics. 9(5). 92–92. 4 indexed citations
14.
Zhi, Xiuyi, Jianxing He, Hui Li, et al.. (2012). Clinical pathway for surgical treatment of primary lung cancer 
(2012 Edition).. PubMed. 4(6). 671–5. 1 indexed citations
15.
Song, Weian, Naikang Zhou, Wei Wang, et al.. (2010). Survival Benefit of Neoadjuvant Chemotherapy in Non-small Cell Lung Cancer: An Updated Meta-Analysis of 13 Randomized Control Trials. Journal of Thoracic Oncology. 5(4). 510–516. 142 indexed citations
16.
Guo, Juntang, et al.. (2010). Giant Solitary Fibrous Tumor of the Pleura: An Analysis of Five Patients. World Journal of Surgery. 34(11). 2553–2557. 24 indexed citations
17.
Chen, Feng, Juntang Guo, Yaxi Zhang, et al.. (2009). Knockdown of c‐FLIPL enhanced AD5‐10 anti‐death receptor 5 monoclonal antibody‐induced apoptosis in human lung cancer cells. Cancer Science. 100(5). 940–947. 8 indexed citations
18.
Guo, Juntang, Chaoyang Liang, Lihua Ding, Naikang Zhou, & Qinong Ye. (2009). Drosophila Eyes Absent Homologue 2 is up-regulated in lung adenocarcinoma. The Chinese-German Journal of Clinical Oncology. 8(12). 681–684. 5 indexed citations
19.
Song, Zuoqing, Xiaohong Xu, Sen Wei, Jun Chen, & Naikang Zhou. (2008). [The expression and clinical significance of heparanase in non-small cell lung cancer.].. PubMed. 11(6). 798–801. 2 indexed citations
20.
Zhou, Naikang, et al.. (2006). [Correlation of 3'-deoxy-3'-18F-fluorothymidine uptake to cell proliferation in lung carcinoma xenografts].. PubMed. 25(12). 1512–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juntang Guo Breakdown of academic impact, for papers by Hans Hamberg Breakdown of academic impact, for papers by Joel L. Mayerson Breakdown of academic impact, for papers by François Casteillo Breakdown of academic impact, for papers by Simone Terra Breakdown of academic impact, for papers by Jane Dancer Breakdown of academic impact, for papers by P S Hasleton Breakdown of academic impact, for papers by Ulisses Ribaldo Nicolau Breakdown of academic impact, for papers by Inge Losen Breakdown of academic impact, for papers by Edina Tolnay
Rankless by CCL
2026